David Seifer leads the corporate and finance group at Bilzin Sumberg Baena Price & Axelrod LLP, and is well-renowned within the market for his experience in mergers and acquisitions, public securities offerings and commercialisation of businesses and products. Seifer’s practice typically spans the life sciences and technology industries within Florida and the US, representing clients such as NOW Diagnostics, Inc.
Legal 500 Editorial commentary
- Profile
Accolades
Miami Elite
Key clients
- NOW Diagnostics, Inc.
Work highlights
Represented NOW Diagnostics, Inc. as lead counsel in a $22.5 million over-subscribed offering to strategic investors, private equity firms, family offices, institutional investors and high net worth individuals in a private placement of the company's Series B preferred stock.